$0.006 0.0 0.0%
Last Trade - 26/02/21
| Market Cap | £3.11m |
| Enterprise Value | £3.11m |
| Revenue | £n/a |
| Position in Universe | th / 6651 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Mar | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018E | 2019E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Lotus Bio-Technology Development Corp., formerly Starflick.Com, is a biotechnology development company. The Company focuses on specializing in the refining of organic materials and the production of natural consumer related products. It is exploring opportunities in the organic growth and farming sector in China. The Company's operations are organizational matters, planning its Websites and developing its business plan. The Company is in start-up stage and has not generated any revenues.
| Last Annual | March 31st, 2017 |
| Last Interim | June 30th, 2017 |
| Incorporated | March 24, 2011 |
| Public Since | March 14, 2013 |
| No. of Shareholders: | n/a |
| No. of Employees: | n/a |
| Sector | Consumer Cyclicals |
| Industry | Media & Publishing |
| Index | |
| Exchange | Pink Sheets on Nasdaq |
| Shares in Issue | 782,775,000 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | Unit 04 16/F Tower 2 Silvercord,30 Canton Road Kowloon, Kowloon, Hong Kong |
| Web | |
| Phone | +852 639 80212 |
| Auditors | Malone Bailey, LLP |
As of 26/02/21, shares in Lotus Bio-Technology Development are trading at $0.006, giving the company a market capitalisation of £3.11m. This share price information is delayed by 15 minutes.
Shares in Lotus Bio-Technology Development are currently trading at $0.006 and the price has moved by 0.206k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Lotus Bio-Technology Development price has moved by 0.138k% over the past year.
There are no analysts currently covering Lotus Bio-Technology Development.
Lotus Bio-Technology Development is scheduled to issue upcoming financial results on the following dates:
Lotus Bio-Technology Development does not currently pay a dividend.
Lotus Bio-Technology Development does not currently pay a dividend.
Lotus Bio-Technology Development does not currently pay a dividend.
To buy shares in Lotus Bio-Technology Development you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Lotus Bio-Technology Development are currently trading at $0.006, giving the company a market capitalisation of £3.11m.
Here are the trading details for Lotus Bio-Technology Development:
We were not able to load our ranking data for Lotus Bio-Technology Development
We were not able to load any forecast data for Lotus Bio-Technology Development.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Lotus Bio-Technology Development. Over the past six months, the relative strength of its shares against the market has been 58.97%. At the current price of $0.006, shares in Lotus Bio-Technology Development are trading at 36.08% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Lotus Bio-Technology Development.
Lotus Bio-Technology Development's management team is headed by:
Here are the top five shareholders of Lotus Bio-Technology Development based on the size of their shareholding:
